|
시장보고서
상품코드
2075261
리소좀 산성 리파아제 결핍증 치료 시장 : 치료법별, 최종사용자별, 유통 채널별, 지역별Lysosomal Acid Lipase Deficiency Treatment Market, By Treatment Type, By End User, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
리소좀 산성 리파아제 결핍증 치료제 시장은 2026년에 4억 7,460만 달러로 추정되고 있으며, 2033년까지 11억 1,650만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 13.0%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 4억 7,460만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 13.00% | 2033년 시장 규모 예측 : | 11억 1,650만 달러 |
전 세계 리소좀성 산성 리파아제 결핍증 치료 시장은 효소 보충 요법, 유전자 치료, 기질 감소 요법 등의 치료 유형으로 구성되어 있으며, 병원·진료소, 전문 치료 센터, 재택 간호 환경 등의 용도에 대응하고 있습니다. 이러한 제품들은 여러 최종사용자 부문 및 기타 분야에서 채택되어 효율성, 성능, 신뢰성 향상에 기여하고 있습니다. 이러한 부문에서의 채용 확대와 지속적인 제품 혁신이 맞물려 시장 확대를 지속적으로 지원하고 있습니다.
시장 역학 :
주요 응용 분야의 수요 증가, 효율성과 성능에 대한 중요성 부각, 그리고 지속적인 제품 혁신이 전 세계 리소좀 산성 리파아제 결핍증 치료 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다. 주요 최종사용자들 사이에서 도입이 확대되고, 첨단 솔루션에 대한 투자가 증가함에 따라 시장 확대에 더욱 박차를 가하고 있습니다.
예를 들어 각 인터넷 서비스 제공업체들은 병원이나 진료소, 그리고 관련 용도에 맞춘 제품 및 서비스 개발을 점점 더 적극적으로 추진하고 있습니다. 또한 지속적인 연구개발과 신기술의 통합을 통해 예측 기간 중 시장 참여자들에게 새로운 성장 기회가 창출될 것으로 전망됩니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 이 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 리소좀성 산성 리파아제 결핍증 치료 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 '세계의 리소좀 산성 리파아제 결핍증 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 리소좀 산성 리파아제 결핍증 치료 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 리소좀 산성 리파아제 결핍증 치료 시장 : 치료 유형별, 2026-2033년
제5장 리소좀 산성 리파아제 결핍증 치료 시장 : 최종사용자별, 2026-2033년
제6장 리소좀 산성 리파아제 결핍증 치료 시장 : 유통 채널별, 2026-2033년
제7장 리소좀 산성 리파아제 결핍증 치료 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.08Lysosomal Acid Lipase Deficiency Treatment Market is estimated to be valued at USD 474.6 million in 2026 and is expected to reach USD 1,116.5 million by 2033, growing at a compound annual growth rate (CAGR) of 13.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 474.6 million |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.00% | 2033 Value Projection: | USD 1,116.5 million |
The global lysosomal acid lipase deficiency treatment market comprises treatment type categories such as Enzyme Replacement Therapy, Gene Therapy, and Substrate Reduction Therapy, serving applications including Hospitals and Clinics, Specialty Treatment Centres, and Home Care Settings. These offerings are adopted across multiple end-use sectors and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.
Market Dynamics:
Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global lysosomal acid lipase deficiency treatment market. Expanding adoption among major end users and growing investment in advanced solutions are further supporting market expansion.
For instance, providers are increasingly developing offerings tailored to Hospitals and Clinics and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lysosomal acid lipase deficiency treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Alexion Pharmaceuticals, Sanofi Genzyme, Amicus Therapeutics, Audentes Therapeutics, Sangamo Therapeutics, Biomarin Pharmaceutical, RareGenix, Apellis Pharmaceuticals, Shire (Takeda), and Moderna Therapeutics, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global lysosomal acid lipase deficiency treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysosomal acid lipase deficiency treatment market.
Detailed Segmentation:
- Global Lysosomal Acid Lipase Deficiency Treatment Market, By Treatment Type (Revenue, USD Mn, 2021 - 2033)
- Enzyme Replacement Therapy
- Gene Therapy
- Substrate Reduction Therapy
- Supportive Care
- Others
- Global Lysosomal Acid Lipase Deficiency Treatment Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Clinics
- Specialty Treatment Centres
- Home Care Settings
- Diagnostic Laboratories
- Others
- Global Lysosomal Acid Lipase Deficiency Treatment Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Direct Sales by Manufacturers
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Alexion Pharmaceuticals*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi Genzyme
- Amicus Therapeutics
- Audentes Therapeutics
- Sangamo Therapeutics
- Biomarin Pharmaceutical
- RareGenix
- Apellis Pharmaceuticals
- Shire (Takeda)
- Moderna Therapeutics
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By End User
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective
- Top Market Players by Revenue
4. Lysosomal Acid Lipase Deficiency Treatment Market, By Treatment Type, 2026-2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Enzyme Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Substrate Reduction Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
5. Lysosomal Acid Lipase Deficiency Treatment Market, By End User, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Specialty Treatment Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
6. Lysosomal Acid Lipase Deficiency Treatment Market, By Distribution Channel, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Direct Sales by Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Million)
7. Lysosomal Acid Lipase Deficiency Treatment Market, By Region, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Benelux
- Denmark
- Norway
- Sweden
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- China
- Taiwan
- India
- Japan
- Indonesia
- Malaysia
- Philippines
- Singapore
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- UAE
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of Middle East
8. Competitive Landscape
- Alexion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi Genzyme
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amicus Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Audentes Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sangamo Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biomarin Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RareGenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Apellis Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shire (Takeda)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Moderna Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
